Keel Point’s MetLife MET Stock Holding History

Keel Point’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,538	Closed	-$250K	–	532
2026 Q1	$250K	Buy	+3,538	New	+$265K	0.02%	388

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Keel Point's MET Position: Q2 2026 in Review

Keel Point sold out of MetLife (MET) in Q2 2026, closing a stake of 3,538 shares — an estimated $250K sold.

Keel Point first reported a position in MET in Q1 2026 and held it in 1 quarter. The position peaked at $250K in Q1 2026. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

Keel Point reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
Keel Point sold 3,538 MetLife shares in Q2 2026, an estimated $250K.
Keel Point first reported a position in MetLife in Q1 2026 and held it in 1 quarter.
Keel Point's MetLife position peaked at $250K in Q1 2026.
1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Keel Point's 13F filing for Q2 2026, filed 14 Aug 2026.